DR GARY MOORE CONSULTING LIMITED
Significant control: Gary William Moore (50–75%), Frank Aparecido Oliva (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Dr Gary Moore Consulting Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Dr Gary Moore Consulting Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
DR GARY MOORE CONSULTING LIMITED is an active private limited company (company number 11159124) incorporated on 19 January 2018, registered in Bexley. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 January 2025, showing net assets of £1,281, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 71% on the prior period (£4,356).
By net assets it sits in the upper half of 151 comparable companies in Greater London (median £200, upper quartile £53k).
Ownership and control
- Dr Gary William Moore
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Mr Frank Aparecido Oliva
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 19 January 20188 yrs ago
- Next accounts due
- 31 October 2026in 2 days
- Confirmation statement due
- 2 February 2027in 96 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | £1,281 | — | — | £650 | — | — | 2 |
| 31 January 2024 | £4,356 | — | — | £831 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £1,281 at 31 January 2025
- Net assets down 25% or more on the prior period-70.6% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 119.11
- Incorporated five or more years agoIncorporated 19 January 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 96 days
- Next accounts duein 2 days
- Accounts period endNet assets £1,281 · micro accounts
- Accounts period endNet assets £4,356 · micro accounts
- Incorporated
Similar companies in Greater London
- ETHERICA LTDCroydon · inc. Jan 2018
- ADVANCED CELL TECHNOLOGIES LTDBarnet · inc. Feb 2018
- AQBIO LIMITEDRichmond · inc. Mar 2018
- ENCELO LABORATORIES LIMITEDHarrow · inc. Dec 2017
- MEDCRYST THERAPEUTICS LTDRickmansworth · inc. Nov 2017
- GENEALFA LIMITEDCroydon · inc. Mar 2018
All companies incorporated on 19 January 2018 · in Jan 2018.
Reminders for DR GARY MOORE CONSULTING LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.